Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Elevated expression of serum soluble ST2 in clinical relapse after stopping long-term Nucleos(t)ide analogue therapy for chronic hepatitis B

Fig. 2

Longitudinal analysis of serum sST2 expression in 91 CHB patients after stopping long-term NA therapy for 48 weeks. a The dynamics of HBV DNA levels in serum in the CR and NCR group. b The dynamics of ALT levels in serum in the CR and NCR group. c The dynamics of sST2 levels in serum in the CR and NCR group. d Changes in serum sST2 between baseline and the point of clinical relapse in CR group and changes in serum sST2 between baseline and 48 W in NCR group. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001

Back to article page